The Effects of Immobilisation and Exercise on Homeostatic Plasticity Mechanisms in Healthy Participants

Sponsor
Aalborg University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05252247
Collaborator
(none)
28
1
1
10.5
2.7

Study Details

Study Description

Brief Summary

Homeostasis is important for maintaining a stable equilibrium of e.g., blood pressure, hormonal release, and release of neurotransmitters. Within the healthy brain, homeostatic plasticity mechanisms ensure stability in synaptic plasticity that maintains cortical excitability within a normal physiological range, while this regulation has been shown to be impaired in chronic pain conditions such as low back pain. Cortical excitability can also be decreased and increased experimentally, using immobilisation and exercise paradigms, respectively, yet it is unknown if this overall change in excitability is caused by a shift in homeostatic plasticity regulation. Investigating if immobilisation and exercise influences homeostatic plasticity responses, may therefore reveal important information on the malleability of homeostatic plasticity mechanisms and ways to modulate them.

Condition or Disease Intervention/Treatment Phase
  • Other: Immobilisation
  • Other: Exercise
N/A

Detailed Description

The aim of this study is to investigate the impact of upper limb immobilisation and physical exercise of the hand on homeostatic plasticity in healthy individuals.

The study will be performed as a randomised cross-over study where each participant take part in three sessions, separated by approximately 24 hours. During each session, the participant will answer questionnaires and undergo quantitative sensory testing (QST). Baseline measures is obtained using transcranial magnetic stimulation (TMS)-induced motor evoked potentials (MEPs), which is done before the induction of homeostatic plasticity using transcranial direct current stimulation (tDCS). MEPs are then obtained every 10 minutes for 30 minutes. Lastly, QST measures are obtained again.

As no previous studies have investigated the effect of immobilisation and exercise on homeostatic plasticity response, a sample size calculation was estimated based on MEP analysis from a previous study using α of 0.05, β of 0.80, and effect size of 0.29, yielding 22 participants. This is consistent with recent exploratory research that suggested that up to 28 participants would be needed. Therefore, the current study aimed at including 28 participants with an interim analysis performed after 10-15 inclusions.

Each participant will attend three identical experimental sessions on the same time on three consecutive days. Eight hours before attending the experimental sessions with immobilisation the participant will be fitted a splint (MANU-Hit DIGITUS POLLEX, Clinical Innovations, DK) to immobilise the right hand. Similarly, eight hours before attending the exercise session, the participant will be instructed to perform 150 ballistic finger movements with a pace of 0.5 Hz. During the experiment, the participant will be seated comfortably with arms and hands at rest. Electromyography electrodes will be placed on the right first interosseous muscle to assess the corticomotor excitability by recording of TMS induced MEPs on the left primary motor cortex. A neoprene cap will then be mounted to the head, and the optimal site for TMS (hotspot) will be identified and marked on the cap for standardisation. The cortical excitability will be measured before and immediately after homeostatic plasticity induction (time point 0-min), and then every 10 minutes for 30 minutes.

Homeostatic plasticity will be induced using tDCS applied to the left primary motor cortex for 7 minutes, followed by a break of 3 minutes and another 5 minutes of tDCS. A constant current of 1mA will be transmitted through the tDCS system (Starstim 32, Neuroelectrics, Barcelona, Spain) using two gelled electrodes placed into holes of a neoprene cap at the position of C3 and Fp2.

The distribution of the data will be tested using a Shapiro-Wilk's test of normality. To investigate the effect of immobilisation and exercise on homeostatic plasticity, a two-way repeated measures analysis of variance (RM-ANOVA) will be conducted with factors Session (Session 1, session 2, and session 3) and Time (baseline, 0 min, 10 min, 20min, and 30 min) and a P value of <0.05 will be considered statistically significant. Adjustments will be made for multiple post-hoc comparisons using appropriate corrections.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This is a within-subject repeated measures comparisons study with one baseline session and two interventional sessions.This is a within-subject repeated measures comparisons study with one baseline session and two interventional sessions.
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Effects of Immobilisation and Exercise on Homeostatic Plasticity Mechanisms in Healthy Participants
Actual Study Start Date :
Feb 15, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Conditions

Participants will attend three sessions where two consist of immobilisation or exercise interventions.

Other: Immobilisation
Eight hours prior to attending the immobilisation session, a splint will be fitted to the hand of the participant and remain until the session start.

Other: Exercise
Eight hours prior to attending the exercise session, the participant will be instructed to perform 150 ballistic finger movements every hour until the session start.

Outcome Measures

Primary Outcome Measures

  1. Corticospinal excitability [Immediately after [0 minutes after homeostatic plasticity induction] and every 10 minutes up until 30 minutes after [10-30 minutes after homeostatic plasticity induction]]

    Change in corticospinal excitability (compared to baseline), as reflected by motor-evoked potential amplitudes induced by transcranial magnetic stimulation, after homeostatic plasticity induction

Secondary Outcome Measures

  1. Quantitative Sensory Testing: Cuff detection threshold [Before and 30 minutes post homeostatic plasticity induction]

    Cuff detection threshold [kPa]

  2. Quantitative Sensory Testing: Cuff pain tolerance threshold [Before and 30 minutes post homeostatic plasticity induction]

    Cuff pain tolerance threshold [kPa]

  3. Quantitative Sensory Testing: Conditioned pain modulation [Before and 30 minutes post homeostatic plasticity induction]

    Conditioned pain modulation [kPa change]

  4. Quantitative Sensory Testing: Temporal summation of pain [Before and 30 minutes post homeostatic plasticity induction]

    Temporal summation of pain [pain rating; Visual analogue scale; 0-10 cm; higher scores means more pain]

  5. Quantitative Sensory Testing: Mechanical pain threshold [Before and 30 minutes post homeostatic plasticity induction]

    Mechanical pain threshold (pin prick) [force required for inducing pricking pain; nM]

  6. Quantitative Sensory Testing: Handheld algometry at right dorsal interosseous muscle [Before and 30 minutes post homeostatic plasticity induction]

    Handheld algometry at right dorsal interosseous muscle [kPa]

  7. Quantitative Sensory Testing: Handheld algometry at left dorsal interosseous muscle [Before and 30 minutes post homeostatic plasticity induction]

    Handheld algometry at left dorsal interosseous muscle [kPa]

  8. Quantitative Sensory Testing: Handheld algometry at right tibialis anterior muscle [Before and 30 minutes post homeostatic plasticity induction]

    Handheld algometry at right tibialis anterior muscle [kPa]

  9. Questionnaires: Pittsburgh Sleep Quality Index [Before baseline corticospinal excitability measurements]

    Pittsburgh Sleep Quality Index (PSQI; 0-21; PSQI > 5 means poor sleep quality)

  10. Questionnaires: Pain Catastrophizing Scale [Before baseline corticospinal excitability measurements]

    Pain Catastrophizing Scale (PCS; 0-52; higher score means more pain catastrophizing)

  11. Questionnaires: International Physical Activity Questionnaire [Before baseline corticospinal excitability measurements]

    International Physical Activity Questionnaire (IPAQ; resting metabolic rate multiplied by activity per minutes performed > higher means better physical activity)

  12. Questionnaires: Positive and Negative Affective Schedule [Before baseline corticospinal excitability measurements]

    Positive and Negative Affective Schedule - Short Form (PANAS; 10-50; higher scores = higher levels of negative or positive affect)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

o Healthy, aged between 18-60 years, right-handed, and can speak, read, and understand Danish or English

Exclusion Criteria:
  • Pregnant or breastfeeding

  • Regular use of cannabis, opioids or other drugs (except contraceptives)

  • Current or previous neurologic, musculoskeletal, mental, or other illnesses (e.g. brain or spinal cord injuries, degenerative neurological disorders, epilepsy, major depression, cardiovascular disease, chronic lung disease, etc.)

  • Current or previous chronic or recurrent pain condition

  • Current regular use of analgesic medication or other medication which may affect the trial (including paracetamol and NSAIDs)

  • Lack of ability to cooperate

  • Recent history of acute pain particularly in the lower limbs (unless related to low back pain in patients included in sub-project 6)

  • Abnormally disrupted sleep in 24 hours preceding experiment

  • Any medical or other condition (i.e. musculoskeletal, cardiorespiratory, neurological, etc.)

  • Contraindications to TMS application (history of epilepsy, metal implants in head or jaw, etc.)

  • Unable to pass the "Transcranial Magnetic Stimulation Adult Safety Screen" or tDCS screening questionnaire

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aalborg University Aalborg Nordjylland Denmark 9220

Sponsors and Collaborators

  • Aalborg University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dennis Boye Larsen, Assistant Professor, Aalborg University
ClinicalTrials.gov Identifier:
NCT05252247
Other Study ID Numbers:
  • N-20210047
First Posted:
Feb 23, 2022
Last Update Posted:
Jul 26, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 26, 2022